Industry News: The 7th annual World Oncology Cell Therapy Congress returns in April 2023
Join world leaders as they discuss the latest advances in the field of cell therapy
The World Oncology Cell Therapy Congress is an annual meeting bringing together drug developers, investors, solution providers and clinicians whose purpose is to deliver safe and effective adoptive cell therapy products to clinical implementation.
As part of the conference, you can enjoy an exclusive pre-event evening networking session centered around overcoming barriers to patient access and facilitating clinical distribution of transformative cell therapy products.
On-stage presentations, panels and Q&As will cover the following themes:
- Breakthroughs and Pipeline Advancements
- New Cell Therapy Platforms and Enabling Technologies
- Manufacturing at Scale and Commercialization
- Pre-event evening expanding into Cell Therapy Access
Download the agenda HERE to discover more about the sessions taking place and the 65+ speaker faculty, including:
- Carnley Norman, Head of Global MSAT, Kite Pharma
- Frank Borriello, CEO, Alloplex Biotherapeutics
- Armon Sharei, CEO, SQZ Biotech
- Rachel Lynn, Associate Director, Research, Lyell Immunopharma
- Geoffrey Hodge, CEO, SOTIO Biotech
Join fellow cell therapy researches in Boston, USA April 25 – 26, 2023 to discover the latest developments in delivering safe and effective adoptive cell therapy products.
Register your place here >>
Want the latest science news straight to your inbox? Become a SelectScience member for free today>>
_(1).gif)
.gif)
Related Articles
- Predictive molecular pathology: Improving clinical outcomes for cancer patients
- 5 upcoming webinars to expand your science
- Owlstone Medical enters partnership with Bicycle Therapeutics
- Liquid handling: The latest piece of equipment to modernize your pipetting workflow
- Waters introduces next-generation HPLC system
- Microplate reading technology for improved assay stability in drug discovery workflows